Paediatric respiratory diseases
Respiratory infections
Mini symposium
Long-term impact of cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis patients and potential changes in the management of the disease in CF units
Translational
Long-term effects of CFTR modulators in cystic fibrosis
Aims : To review the expected changes associated with the introduction of cystic fibrosis transmembrane conductance regulator (CFTR) modulators in the management of CF patients; to particularly review how the clinical management of paediatric and adult CF patients could change in the future considering the potential benefits of these drugs on disease progression, but also in consideration of potential side effects; to discuss the perspective of early treatment in CF children and the applications of CFTR modulators in special subgroups of CF patients, such as nonresponders and those with rare mutations; to provide a session that is intentionally translational and directed at different specialists and disciplines involved in the management of CF patients.
Target audience :
Adult pulmonologist/Clinician, Clinical researcher, General practitioner, Medical Student, Medical Technical Assistant, Nurse, Paediatrician, Patient, Physician in Pulmonary Training, Physiologist, Respiratory physiotherapist, Scientist (basic, translational), Respiratory therapist, Journalist
Methods :
Cell and molecular biology, Epidemiology
14:15
How CFTR modulators are expected to change the management of CF and its comorbidities
S. Elborn(Belfast (Belfast), United Kingdom)
COI
-
Description
1
4369
14:30
Impact of CFTR modulators on disease progression in children with CF
M. Mall(Berlin, Germany)
COI
-
Description
2
4370
14:45
Nonresponders and rare mutation classes: ex vivo models to test CFTR modulator efficacy
I. Oglesby(Beaumont, Ireland)
COI
-
Description
3
4371
15:00
Discussion and Q&A
4
4372
. . .